{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:50:10Z","timestamp":1789617010527,"version":"build-2803163510"},"reference-count":202,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023673","name":"Deanship of Scientific Research, Imam Mohammed Ibn Saud Islamic University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007470","name":"Shaqra University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007470","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.lfs.2024.122950","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T06:59:46Z","timestamp":1723186786000},"page":"122950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Approaches based on miRNAs in Beh\u00e7et's Disease: Unveiling pathogenic mechanisms, diagnostic strategies, and therapeutic applications"],"prefix":"10.1016","volume":"354","author":[{"given":"Mohamed","family":"Hemdan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif S.","family":"Abdel Mageed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed I.","family":"Abulsoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed H.I.","family":"Faraag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Bakr","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reda M.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Amr","family":"Raouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram N.","family":"Salah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Ahmed","family":"Abdel-Reheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Doghish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.122950_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1055753","article-title":"Innate immune responses in Beh\u00e7et disease and relapsing polychondritis","volume":"10","author":"Shimizu","year":"2023","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.lfs.2024.122950_bb0010","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3390\/life13051157","article-title":"Challenges in the timely diagnosis of Behcet\u2019s disease","volume":"13","author":"Hassan","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.lfs.2024.122950_bb0015","doi-asserted-by":"crossref","unstructured":"J. Rodr\u00edguez-Carrio, V. Nucera, I.F. Masala, F. Atzeni, Beh\u00e7et disease: from pathogenesis to novel therapeutic options, Pharmacol. Res. 167 (2021) 105593.","DOI":"10.1016\/j.phrs.2021.105593"},{"issue":"2","key":"10.1016\/j.lfs.2024.122950_bb0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1517\/14656566.5.2.317","article-title":"Managing the symptoms of Beh\u00e7et\u2019s disease","volume":"5","author":"Evereklioglu","year":"2004","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.lfs.2024.122950_bb0025","series-title":"Clinical manifestations and diagnosis of Beh\u00e7et\u2019s syndrome, UpToDate [updated on 23.11]","author":"Smith","year":"2020"},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2024.122950_bb0030","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.5152\/eurjrheum.2019.19121","article-title":"Pediatric Beh\u00e7et\u2019s disease-clinical aspects and current concepts","volume":"7","author":"Y\u0131ld\u0131z","year":"2020","journal-title":"European journal of rheumatology"},{"issue":"22","key":"10.1016\/j.lfs.2024.122950_bb0035","doi-asserted-by":"crossref","first-page":"16382","DOI":"10.3390\/ijms242216382","article-title":"Beh\u00e7et\u2019s disease: a comprehensive review on the role of HLA-B* 51, antigen presentation, and inflammatory cascade","volume":"24","author":"Khoshbakht","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2024.122950_bb0040","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00004836-200003000-00006","article-title":"Gastrointestinal manifestations of Behcet\u2019s disease","volume":"30","author":"Bayraktar","year":"2000","journal-title":"J. Clin. Gastroenterol."},{"issue":"2","key":"10.1016\/j.lfs.2024.122950_bb0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrrheum.2012.156","article-title":"Differential diagnosis and management of Beh\u00e7et syndrome","volume":"9","author":"Ambrose","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/diagnostics13010041","article-title":"Update on the diagnosis of Beh\u00e7et\u2019s disease","volume":"13","author":"Alibaz-Oner","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.lfs.2024.122950_bb0055","doi-asserted-by":"crossref","first-page":"151956","DOI":"10.1016\/j.semarthrit.2022.151956","article-title":"Immunopathogenesis of Beh\u00e7et's disease and treatment modalities","author":"Van der Houwen","year":"2022","journal-title":"Seminars in Arthritis and Rheumatism, Elsevier"},{"key":"10.1016\/j.lfs.2024.122950_bb0060","article-title":"Risk factors, clinical features and treatment of Beh\u00e7et\u2019s disease uveitis","volume":"101216","author":"Zhong","year":"2023","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.lfs.2024.122950_bb0065","article-title":"Infectious agents and pathogenesis of Beh\u00e7et\u2019s disease: an extensive review","volume":"109631","author":"Cheng","year":"2023","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122950_bb0070","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s40257-021-00609-4","article-title":"Beh\u00e7et disease: an update for dermatologists","volume":"22","author":"Alpsoy","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"issue":"7","key":"10.1016\/j.lfs.2024.122950_bb0075","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.autrev.2015.02.009","article-title":"The role of infections in Beh\u00e7et disease and neuro-Beh\u00e7et syndrome","volume":"14","author":"Marta","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.lfs.2024.122950_bb0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.autrev.2014.11.009","article-title":"Beh\u00e7et\u2019s syndrome patients exhibit specific microbiome signature","volume":"14","author":"Consolandi","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.lfs.2024.122950_bb0085","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1136\/ard-2022-222277","article-title":"Beh\u00e7et\u2019s disease risk-variant HLA-B51\/ERAP1-Hap10 alters human CD8 T cell immunity","volume":"81","author":"Cavers","year":"2022","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.lfs.2024.122950_bb0090","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.rdc.2023.03.010","article-title":"Beh\u00e7et Syndrome","volume":"49","author":"Hatemi","year":"2023","journal-title":"Rheum. Dis. Clin."},{"issue":"3","key":"10.1016\/j.lfs.2024.122950_bb0095","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s10038-019-0709-y","article-title":"Variant in ERAP1 promoter region is associated with low expression in a patient with a Beh\u00e7et-like MHC-I-opathy","volume":"65","author":"Dimopoulou","year":"2020","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.lfs.2024.122950_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1274960","article-title":"The association of chemokine gene polymorphisms with VKH and Behcet\u2019s disease in a Chinese Han population","volume":"2017","author":"Huang","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cei.13049","article-title":"Is Beh\u00e7et's disease a \u2018class 1-opathy\u2019? The role of HLA-B* 51 in the pathogenesis of Beh\u00e7et's disease","volume":"191","author":"Giza","year":"2018","journal-title":"Clinical & Experimental Immunology"},{"issue":"9","key":"10.1016\/j.lfs.2024.122950_bb0110","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2169\/internalmedicine.2035-18","article-title":"Clinical and genetic aspects of Beh\u00e7et\u2019s disease in Japan","volume":"58","author":"Kirino","year":"2019","journal-title":"Intern. Med."},{"issue":"2","key":"10.1016\/j.lfs.2024.122950_bb0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.berh.2018.08.010","article-title":"Update on the epidemiology, risk factors and disease outcomes of Beh\u00e7et\u2019s disease","volume":"32","author":"Akko\u00e7","year":"2018","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.lfs.2024.122950_bb0120","doi-asserted-by":"crossref","unstructured":"U. Uygunoglu, A. Siva, An uncommon disease included commonly in the differential diagnosis of neurological diseases: neuro-Beh\u00e7et's syndrome, J. Neurol. Sci. 426 (2021) 117436.","DOI":"10.1016\/j.jns.2021.117436"},{"key":"10.1016\/j.lfs.2024.122950_bb0125","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1007\/s00415-017-8436-9","article-title":"Neurological complications of Beh\u00e7et\u2019s syndrome","volume":"264","author":"Kidd","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.lfs.2024.122950_bb0130","series-title":"Vascular Involvement in Beh\u00e7et\u2019s Disease: A Retrospective Analysis of 2319 Cases","author":"Sarica-Kucukoglu","year":"2006"},{"issue":"9","key":"10.1016\/j.lfs.2024.122950_bb0135","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1191\/0961203305lu2208oa","article-title":"Beh\u00e7et\u2019s disease and cardiovascular involvement","volume":"14","author":"Atzeni","year":"2005","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.lfs.2024.122950_bb0140","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.jfo.2019.02.002","article-title":"Eye and Beh\u00e7et's disease","volume":"42","author":"Ksiaa","year":"2019","journal-title":"Journal francais d'ophtalmologie"},{"key":"10.1016\/j.lfs.2024.122950_bb0145","series-title":"An Exploration of Non-Antineutrophil Cytoplasmic Antibodies Serum Biomarkers in Systemic Vasculitis: An Investigation of Beh\u00e7et\u2019s Disease","author":"Zeidan","year":"2015"},{"key":"10.1016\/j.lfs.2024.122950_bb0150","series-title":"Pathology-Research and Practice","first-page":"154438","article-title":"Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance-A review","author":"Al-Noshokaty","year":"2023"},{"key":"10.1016\/j.lfs.2024.122950_bb0155","series-title":"Pathology-Research and Practice","first-page":"154457","article-title":"miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses","author":"El-Mahdy","year":"2023"},{"key":"10.1016\/j.lfs.2024.122950_bb0160","series-title":"Pathology-Research and Practice","first-page":"154437","article-title":"The interplay of signaling pathways with miRNAs in cholangiocarcinoma pathogenicity and targeted therapy","author":"Zaki","year":"2023"},{"key":"10.1016\/j.lfs.2024.122950_bb0165","series-title":"Pathology-Research and Practice","first-page":"154511","article-title":"miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay","author":"Elshaer","year":"2023"},{"key":"10.1016\/j.lfs.2024.122950_bb0170","series-title":"Pathology-Research and Practice","first-page":"154439","article-title":"miRNAs as potential game-changers in renal cell carcinoma: Future clinical and medicinal uses","author":"Elballal","year":"2023"},{"key":"10.1016\/j.lfs.2024.122950_bb0175","doi-asserted-by":"crossref","first-page":"1249826","DOI":"10.3389\/fimmu.2023.1249826","article-title":"The role of miRNAs in Beh\u00e7et\u2019s disease","volume":"14","author":"Gu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122950_bb0180","first-page":"2405150","article-title":"MicroRNA expression profiling in Beh\u00e7et\u2019s disease","volume":"1","author":"Puccetti","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"6 Suppl 102","key":"10.1016\/j.lfs.2024.122950_bb0185","first-page":"S56","article-title":"MicroRNA-155 regulates the Th17 immune response by targeting Ets-1 in Beh\u00e7et\u2019s disease","volume":"34","author":"Na","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122950_bb0190","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/jcp.27207","article-title":"Disturbed Th17\/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet\u2019s disease","volume":"234","author":"Ahmadi","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.lfs.2024.122950_bb0195","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/jir.2018.0116","article-title":"Role of serum miR-181b, proinflammatory cytokine, and adhesion molecules in Beh\u00e7et\u2019s disease","volume":"39","author":"El Boghdady","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.lfs.2024.122950_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12950-016-0130-7","article-title":"MicroRNAs differentially expressed in Beh\u00e7et disease are involved in interleukin-6 production","volume":"13","author":"Woo","year":"2016","journal-title":"J. Inflamm."},{"issue":"4","key":"10.1016\/j.lfs.2024.122950_bb0205","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/08820139.2021.1883647","article-title":"Role of miR-146a rs2910164 and UTS2 rs228648 genetic variants in Behcet\u2019s disease","volume":"51","author":"Kamal","year":"2022","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.lfs.2024.122950_bb0210","doi-asserted-by":"crossref","unstructured":"N.A. Mehana, H.R. Ghaiad, M. Hassan, Y.A. Elsabagh, S. Labib, M.A. Abd-Elmawla, LncRNA MEG3 regulates the interplay between Th17 and Treg cells in Beh\u00e7et's disease and systemic lupus erythematosus, Life Sci. 309 (2022) 120965.","DOI":"10.1016\/j.lfs.2022.120965"},{"issue":"4","key":"10.1016\/j.lfs.2024.122950_bb0215","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/iovs.64.4.28","article-title":"Effects of plasma-derived Exosomal miRNA-19b-3p on Treg\/T helper 17 cell imbalance in Beh\u00e7et\u2019s uveitis","volume":"64","author":"Jiang","year":"2023","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2024.122950_bb0220","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4161\/auto.8.2.18845","article-title":"Direct molecular interactions between Beclin 1 and the canonical NF\u03baB activation pathway","volume":"8","author":"Niso-Santano","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.lfs.2024.122950_bb0225","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00439-013-1346-8","article-title":"A functional variant of pre-miRNA-196a2 confers risk for Behcet\u2019s disease but not for Vogt\u2013Koyanagi\u2013Harada syndrome or AAU in ankylosing spondylitis","volume":"132","author":"Qi","year":"2013","journal-title":"Hum. Genet."},{"key":"10.1016\/j.lfs.2024.122950_bb0230","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3389\/fgene.2019.00626","article-title":"Circulating MicroRNAs in cancer: potential and challenge","volume":"10","author":"Cui","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.lfs.2024.122950_bb0235","doi-asserted-by":"crossref","unstructured":"C. Li, P. Dou, T. Wang, X. Lu, G. Xu, X. Lin, Defining disease-related modules based on weighted miRNA synergistic network, Comput. Biol. Med. 152 (2022) 106382.","DOI":"10.1016\/j.compbiomed.2022.106382"},{"issue":"3","key":"10.1016\/j.lfs.2024.122950_bb0240","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jcp.21993","article-title":"Genomic organization of microRNAs","volume":"222","author":"Olena","year":"2010","journal-title":"J. Cell. Physiol."},{"issue":"10a","key":"10.1016\/j.lfs.2024.122950_bb0245","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1101\/gr.2722704","article-title":"Identification of mammalian microRNA host genes and transcription units","volume":"14","author":"Rodriguez","year":"2004","journal-title":"Genome Res."},{"issue":"7014","key":"10.1016\/j.lfs.2024.122950_bb0250","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","article-title":"Processing of primary microRNAs by the microprocessor complex","volume":"432","author":"Denli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2024.122950_bb0255","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.mito.2022.08.002","article-title":"Mitochondrial miRNAs (MitomiRs): their potential roles in breast and other cancers","volume":"66","author":"Erturk","year":"2022","journal-title":"Mitochondrion"},{"issue":"10","key":"10.1016\/j.lfs.2024.122950_bb0260","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41477-021-01000-1","article-title":"Structural basis of microRNA processing by dicer-like 1","volume":"7","author":"Wei","year":"2021","journal-title":"Nat Plants"},{"issue":"11","key":"10.1016\/j.lfs.2024.122950_bb0265","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1101\/gad.1919710","article-title":"Emerging paradigms of regulated microRNA processing","volume":"24","author":"Newman","year":"2010","journal-title":"Genes Dev."},{"issue":"12","key":"10.1016\/j.lfs.2024.122950_bb0270","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in action: biogenesis, function and regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.lfs.2024.122950_bb0275","series-title":"Regulation of microRNAs, miRNomics","first-page":"1","author":"Ergin","year":"2022"},{"issue":"7149","key":"10.1016\/j.lfs.2024.122950_bb0280","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05983","article-title":"Intronic microRNA precursors that bypass Drosha processing","volume":"448","author":"Ruby","year":"2007","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.lfs.2024.122950_bb0285","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1101\/gad.1705308","article-title":"Mouse ES cells express endogenous shRNAs, siRNAs, and other microprocessor-independent, Dicer-dependent small RNAs","volume":"22","author":"Babiarz","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.lfs.2024.122950_bb0290","series-title":"miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis","first-page":"276","volume":"9(2)","author":"Condrat","year":"2020"},{"issue":"7","key":"10.1016\/j.lfs.2024.122950_bb0295","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1134\/S0006297921070014","article-title":"MicroRNAs in cancer: from gene expression regulation to the metastatic niche reprogramming","volume":"86","author":"Semina","year":"2021","journal-title":"Biochem. Mosc."},{"key":"10.1016\/j.lfs.2024.122950_bb0300","doi-asserted-by":"crossref","unstructured":"G. Bagni, G. Emmi, E. Lastraioli, F. Di Patti, E. Silvestri, A. Guerriero, S. Pillozzi, E. Niccolai, A. Amedei, L. Emmi, D. Prisco, A. Arcangeli, Circulating miRNome profiling data in Beh\u00e7et's syndrome, Data Brief 38 (2021) 107435.","DOI":"10.1016\/j.dib.2021.107435"},{"key":"10.1016\/j.lfs.2024.122950_bb0305","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Frontiers in endocrinology"},{"key":"10.1016\/j.lfs.2024.122950_bb0310","series-title":"The role of miRNAs in Beh\u00e7et\u2019s disease","volume":"14","author":"Gu","year":"2023"},{"issue":"04","key":"10.1016\/j.lfs.2024.122950_bb0315","first-page":"538","article-title":"The pathgenetic role and potential clinical application of miRNAs in patients with Behcet\u2019s disease","volume":"44","author":"Jing-Fen","year":"2017","journal-title":"Fudan University J. Med. Sci."},{"key":"10.1016\/j.lfs.2024.122950_bb0320","doi-asserted-by":"crossref","first-page":"2405150","DOI":"10.1155\/2018\/2405150","article-title":"MicroRNA expression profiling in Beh\u00e7et\u2019s disease","volume":"2018","author":"Puccetti","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0325","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s43042-020-00085-1","article-title":"Expression of miR-146a and miR-155 in Egyptian patients with Beh\u00e7et\u2019s disease: clinical significance and relationship with disease activity","volume":"21","author":"El Khateeb","year":"2020","journal-title":"Egyptian Journal of Medical Human Genetics"},{"key":"10.1016\/j.lfs.2024.122950_bb0330","doi-asserted-by":"crossref","first-page":"151956","DOI":"10.1016\/j.semarthrit.2022.151956","article-title":"Immunopathogenesis of Beh\u00e7et\u2019s disease and treatment modalities","volume":"52","author":"Van der Houwen","year":"2022","journal-title":"In Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.lfs.2024.122950_bb0335","doi-asserted-by":"crossref","unstructured":"Z. Zhong, Su, G., & Yang, P., Risk factors, clinical features and treatment of Beh\u00e7et's disease uveitis, Prog. Retin. Eye Res. (2023) 101216.","DOI":"10.1016\/j.preteyeres.2023.101216"},{"issue":"2","key":"10.1016\/j.lfs.2024.122950_bb0340","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/08830185.2020.1851372","article-title":"A comprehensive overview on the genetics of Beh\u00e7et\u2019s diseas","volume":"41","author":"Mahmoudi","year":"2022","journal-title":"Int. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2024.122950_bb0345","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41584-022-00880-7","article-title":"Vascular Beh\u00e7et syndrome: from pathogenesis to treatment","volume":"19","author":"Bettiol","year":"2023","journal-title":"Nature Reviews Rheumatology"},{"issue":"6","key":"10.1016\/j.lfs.2024.122950_bb0350","doi-asserted-by":"crossref","first-page":"8055","DOI":"10.1002\/jcp.27576","article-title":"Behcet\u2019s disease: an immunogenetic perspective","volume":"234","author":"Salmaninejad","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2024.122950_bb0355","doi-asserted-by":"crossref","unstructured":"J. Rodr\u00edguez-Carrio, Nucera, V., Masala, I. F., & Atzeni, F., Beh\u00e7et disease: from pathogenesis to novel therapeutic options, Pharmacol. Res. (167) (2021) 105593.","DOI":"10.1016\/j.phrs.2021.105593"},{"key":"10.1016\/j.lfs.2024.122950_bb0360","doi-asserted-by":"crossref","unstructured":"I. Mattioli, Bettiol, A., Saruhan-Direskeneli, G., Direskeneli, H., & Emmi, G., Pathogenesis of Beh\u00e7et's syndrome: genetic, environmental and immunological factors, Front. Med. 8 (2021) 713052.","DOI":"10.3389\/fmed.2021.713052"},{"issue":"7","key":"10.1016\/j.lfs.2024.122950_bb0365","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/sj.jid.5700281","article-title":"HLA-independent antibacterial host response toward Th1 immunity mediated by IL-12: a new concept for the pathogenesis of Adamantiades\u2013Beh\u00e7et\u2019s disease","volume":"126","author":"Zouboulis","year":"2006","journal-title":"J. Invest. Dermatol."},{"issue":"9","key":"10.1016\/j.lfs.2024.122950_bb0370","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2169\/internalmedicine.2035-18","article-title":"Clinical and genetic aspects of Beh\u00e7et\u2019s disease in Japan","volume":"58","author":"Kirino","year":"2019","journal-title":"Intern. Med."},{"key":"10.1016\/j.lfs.2024.122950_bb0375","series-title":"Internal and Emergency Medicine","first-page":"639","article-title":"Beh\u00e7et\u2019s syndrome: focus on pathogenetic background, clinical phenotypes and specific treatments","volume":"14","author":"Emmi","year":"2019"},{"key":"10.1016\/j.lfs.2024.122950_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13317-016-0074-1","article-title":"Beh\u00e7et\u2019s disease physiopathology: a contemporary review","volume":"7","author":"Zeidan","year":"2016","journal-title":"Autoimmun. Highlights"},{"issue":"3","key":"10.1016\/j.lfs.2024.122950_bb0385","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/jid.2011.397","article-title":"Identification of HnRNP-A2\/B1 as a Target Antigen of Anti-Endothelial Cell IgA Antibody in Behc\u00b8et\u2019s Disease","volume":"132","author":"Cho","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2024.122950_bb0390","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3389\/fimmu.2019.00665","article-title":"Immunopathogenesis of Behcet\u2019s disease","volume":"10","author":"Tong","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0395","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/rheumatology\/keab253","article-title":"Regulatory T cell\/Th17 balance in the pathogenesis of paediatric Beh\u00e7et disease","volume":"61","author":"Filleron","year":"2022","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.lfs.2024.122950_bb0400","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000520696","article-title":"Behcet\u2019s disease: an in-depth review about pathogenesis, gastrointestinal manifestations, and management","volume":"6","author":"Nguyen","year":"2021","journal-title":"Inflammatory Intestinal Diseases"},{"key":"10.1016\/j.lfs.2024.122950_bb0405","series-title":"Pathology Research International","article-title":"Pathophysiology of the Behcet's Disease","author":"T\u00fcrsen","year":"2012"},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0410","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/cbdd.13658","article-title":"Molecular dynamics simulations provide molecular insights into the role of HLA-B51 in Beh\u00e7et\u2019s disease pathogenesis","volume":"96","author":"Gur","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0415","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1167\/iovs.18-25548","article-title":"Effect of interferon alfa-2a treatment on adaptive and innate immune systems in patients with Beh\u00e7et disease uveitis","volume":"60","author":"Albayrak","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.lfs.2024.122950_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.987393","article-title":"Mucocutaneous manifestations of Beh\u00e7et\u2019s disease: pathogenesis and management from perspectives of vasculitis","volume":"9","author":"Kim","year":"2022","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.lfs.2024.122950_bb0425","first-page":"172","article-title":"Beh\u00e7et\u2019s disease: a clinical review","volume":"28","author":"Al-Musawi","year":"2020","journal-title":"Journal of University of Babylon for Pure and Applied Sciences"},{"key":"10.1016\/j.lfs.2024.122950_bb0430","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.imlet.2021.11.004","article-title":"IL-17A and IFN-\u03b3 are up-regulated in CD4 and \u03b3\u03b4 T cells in active Behcet\u2019s disease patients","volume":"242","author":"Abbasova","year":"2022","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0435","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.humimm.2015.10.001","article-title":"In vitro evaluation of \u03b3\u03b4 T cells regulatory function in Beh\u00e7et\u2019s disease patients and healthy controls","volume":"77","author":"Ximenis","year":"2016","journal-title":"Hum. Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2024.122950_bb0440","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1109\/TCBB.2021.3053429","article-title":"The determination of distinctive single nucleotide polymorphism sets for the diagnosis of Beh\u00e7et\u2019s disease","volume":"19","author":"I\u015f\u0131k","year":"2021","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform."},{"issue":"8","key":"10.1016\/j.lfs.2024.122950_bb0445","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/ced.14766","article-title":"Association of single nucleotide polymorphisms in CXCR1, CXCR2 and CXCL5 with Beh\u00e7et disease: a study in the Denizli province of Turkey","volume":"46","author":"Ar\u0131kan","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"issue":"8","key":"10.1016\/j.lfs.2024.122950_bb0450","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0161-6420(85)33911-8","article-title":"Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet\u2019s disease, and sympathetic ophthalmia","volume":"92","author":"Chan","year":"1985","journal-title":"Ophthalmology"},{"issue":"4 Suppl 30","key":"10.1016\/j.lfs.2024.122950_bb0455","first-page":"S27","article-title":"Anti-endothelial cell antibodies in Beh\u00e7et\u2019s disease","volume":"21","author":"Dinc","year":"2003","journal-title":"Clin. Exp. Rheumatol."},{"issue":"16","key":"10.1016\/j.lfs.2024.122950_bb0460","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.2169\/internalmedicine.55.5413","article-title":"Beh\u00e7et\u2019s disease and anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis","volume":"55","author":"Oygar","year":"2016","journal-title":"Internal medicine (Tokyo, Japan)"},{"issue":"2","key":"10.1016\/j.lfs.2024.122950_bb0465","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/14397595.2013.854071","article-title":"Autoantibodies against complement C1q in patients with Behcet\u2019s disease: association with vascular involvement","volume":"24","author":"Bassyouni","year":"2014","journal-title":"Mod. Rheumatol."},{"issue":"6","key":"10.1016\/j.lfs.2024.122950_bb0470","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s10067-021-06025-7","article-title":"Anti-tubulin-alpha-1c antibody as a marker of value in Beh\u00e7et syndrome","volume":"41","author":"Amin","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.lfs.2024.122950_bb0475","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3389\/fimmu.2019.01067","article-title":"Beh\u00e7et\u2019s disease: an overview of etiopathogenesis","volume":"10","author":"Leccese","year":"2019","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.lfs.2024.122950_bb0480","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ng.625","article-title":"Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Beh\u00e7et\u2019s disease","volume":"42","author":"Remmers","year":"2010","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.lfs.2024.122950_bb0485","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/art.24642","article-title":"HLA-B51\/B5 and the risk of Beh\u00e7et\u2019s disease: a systematic review and meta-analysis of case-control genetic association studies","volume":"61","author":"de Menthon","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.lfs.2024.122950_bb0490","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng.2520","article-title":"Genome-wide association analysis identifies new susceptibility loci for Beh\u00e7et\u2019s disease and epistasis between HLA-B*51 and ERAP1","volume":"45","author":"Kirino","year":"2013","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.lfs.2024.122950_bb0495","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00109-014-1159-9","article-title":"Predisposition to Beh\u00e7et\u2019s disease and VKH syndrome by genetic variants of miR-182","volume":"92","author":"Yu","year":"2014","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.lfs.2024.122950_bb0500","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12950-016-0130-7","article-title":"MicroRNAs differentially expressed in Beh\u00e7et disease are involved in interleukin-6 production","volume":"13","author":"Woo","year":"2016","journal-title":"Journal of inflammation (London, England)"},{"key":"10.1016\/j.lfs.2024.122950_bb0505","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.biopha.2017.04.106","article-title":"Epigenetic alterations in chronic disease focusing on Beh\u00e7et's disease: Review","volume":"91","author":"Alipour","year":"2017","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.lfs.2024.122950_bb0510","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.713052","article-title":"Pathogenesis of Beh\u00e7et\u2019s syndrome: genetic, environmental and immunological factors","volume":"8","author":"Mattioli","year":"2021","journal-title":"Frontiers in medicine"},{"issue":"5","key":"10.1016\/j.lfs.2024.122950_bb0515","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/rheumatology\/ket438","article-title":"Increased notch pathway activation in Behcet\u2019s disease","volume":"53","author":"Qi","year":"2014","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.lfs.2024.122950_bb0520","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/nm.2815","article-title":"The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-\u03b1","volume":"18","author":"Zhu","year":"2012","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0525","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-021-02517-8","article-title":"Decreased microRNA-155 in Behcet\u2019s disease leads to defective control of autophagy thereby stimulating excessive proinflammatory cytokine production","volume":"23","author":"Liang","year":"2021","journal-title":"Arthritis Res. Ther."},{"issue":"13","key":"10.1016\/j.lfs.2024.122950_bb0530","doi-asserted-by":"crossref","first-page":"8280","DOI":"10.1167\/iovs.15-18035","article-title":"Association of <i>ATG5<\/i> gene polymorphisms with Behcet\u2019s disease and <i>ATG10<\/i> gene polymorphisms with VKH syndrome in a Chinese Han population","volume":"56","author":"Zheng","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.lfs.2024.122950_bb0535","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1167\/iovs.12-9832","article-title":"Decreased microRNA-155 expression in ocular Behcet\u2019s disease but not in Vogt Koyanagi Harada syndrome","volume":"53","author":"Zhou","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0540","first-page":"195","article-title":"Regulatory role of circRNA-0067835 in Behcet disease through targeting Micro RNA-155: implication of <i>ATG1, AKT<\/i> and <i>MTOR<\/i>","volume":"12","author":"El-Din","year":"2023","journal-title":"Reports of Biochemistry and Molecular Biology"},{"issue":"2","key":"10.1016\/j.lfs.2024.122950_bb0545","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/bjophthalmol-2017-311079","article-title":"MicroRNA-20a-5p suppresses IL-17 production by targeting OSM and CCL1 in patients with Vogt-Koyanagi-Harada disease","volume":"102","author":"Chang","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.lfs.2024.122950_bb0550","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00399","article-title":"NF-\u03baB pathway in autoinflammatory diseases: dysregulation of protein modifications by ubiquitin defines a new category of autoinflammatory diseases","volume":"8","author":"Aksentijevich","year":"2017","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.lfs.2024.122950_bb0555","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.autrev.2016.09.003","article-title":"The role of microRNAs in the pathogenesis of autoimmune diseases","volume":"15","author":"Chen","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.lfs.2024.122950_bb0560","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/jcp.27207","article-title":"Disturbed Th17\/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet\u2019s disease","volume":"234","author":"Ahmadi","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2024.122950_bb0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2018.04.019","article-title":"MicroRNA-326 aggravates acute lung injury in septic shock by mediating the NF-\u03baB signaling pathway","volume":"101","author":"Wu","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.lfs.2024.122950_bb0570","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/rheumatology\/ket438","article-title":"Increased notch pathway activation in Behcet\u2019s disease","volume":"53","author":"Qi","year":"2014","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0575","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13075-021-02517-8","article-title":"Decreased microRNA-155 in Behcet\u2019s disease leads to defective control of autophagy thereby stimulating excessive proinflammatory cytokine production","volume":"23","author":"Liang","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.lfs.2024.122950_bb0580","unstructured":"A.M.A. Albalawi, Identifying Genetic Variation Underlying Vogt-Koyanagi-Harada (VKH) in Saudi Patients Using Exome Sequencing."},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0585","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/16878507.2021.1909223","article-title":"Assessment of T regulatory cells in Egyptian patients with Behcet\u2019s disease as a prognostic marker of uveitis","volume":"14","author":"Eissa","year":"2021","journal-title":"Journal of Radiation Research and Applied Sciences"},{"key":"10.1016\/j.lfs.2024.122950_bb0590","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3389\/fimmu.2019.01067","article-title":"Beh\u00e7et\u2019s disease: an overview of etiopathogenesis","volume":"10","author":"Leccese","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2024.122950_bb0595","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s12026-022-09298-5","article-title":"Effect of different cytokines in combination with IL-15 on the expression of activating receptors in NK cells of patients with Beh\u00e7et\u2019s disease","volume":"70","author":"Sallakci","year":"2022","journal-title":"Immunol. Res."},{"key":"10.1016\/j.lfs.2024.122950_bb0600","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3389\/fimmu.2019.01969","article-title":"Metabolism and autoimmune responses: the microRNA connection","author":"Colamatteo","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.122950_bb0605","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221093595","article-title":"The extensive regulation of MicroRNA in immune thrombocytopenia","volume":"28","author":"Zhao","year":"2022","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"3","key":"10.1016\/j.lfs.2024.122950_bb0610","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/cmi.2010.19","article-title":"microRNAs: critical regulators in Th17 cells and players in diseases","volume":"7","author":"Wei","year":"2010","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0615","doi-asserted-by":"crossref","first-page":"19101","DOI":"10.1038\/s41598-023-44767-3","article-title":"Next generation sequencing uncovers multiple miRNAs associated molecular targets in gallbladder cancer patients","volume":"13","author":"Saxena","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2024.122950_bb0620","series-title":"Gene Expression of Inhibitory Receptors and Immune Regulatory Molecules in Polarized Macrophages Derived from Early-and Late-Stage BD Patients, Available at SSRN 3901856","author":"Antqueviezc","year":"2021"},{"issue":"2","key":"10.1016\/j.lfs.2024.122950_bb0625","first-page":"161","article-title":"Role of the pro-inflammatory cytokines tumor necrosis factor-alpha, interleukin-1beta, interleukin-6 and interleukin-8 in the pathogenesis of the otitis media with effusion","volume":"13","author":"Smirnova","year":"2002","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.lfs.2024.122950_bb0630","first-page":"617","article-title":"Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor-, interleukin-1 and cholecystokinin-8: the possible role of NGF in the inflammatory response","volume":"21","author":"Manni","year":"2003","journal-title":"Clin. Exp. Rheumatol."},{"issue":"13","key":"10.1016\/j.lfs.2024.122950_bb0635","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.3390\/jcm12134446","article-title":"Circular RNA as therapeutic targets in atherosclerosis: are we running in circles?","volume":"12","author":"Triska","year":"2023","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.lfs.2024.122950_bb0640","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.21037\/jgo-22-1126","article-title":"The novel epithelial-mesenchymal transition-related proteins and their therapeutic targets in cholangiocarcinoma: a narrative review","volume":"14","author":"Kimawaha","year":"2023","journal-title":"Journal of Gastrointestinal Oncology"},{"key":"10.1016\/j.lfs.2024.122950_bb0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/5047501","article-title":"Identification of potential therapeutic targets and molecular regulatory mechanisms for osteoporosis by bioinformatics methods","volume":"2021","author":"Zhang","year":"2021","journal-title":"Biomed. Res. Int."},{"issue":"5","key":"10.1016\/j.lfs.2024.122950_bb0650","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.51248\/.v43i5.3258","article-title":"Assessing miR-146a-5P with IL-6 and TLR-4 serum levels in diabetic mellitus patients with or without urinary tract infection","volume":"43","author":"Thajel","year":"2023","journal-title":"Biomedicine"},{"issue":"3","key":"10.1016\/j.lfs.2024.122950_bb0655","doi-asserted-by":"crossref","DOI":"10.17161\/rrnmf.v4i3.19526","article-title":"MiR-146a in myasthenia gravis thymus: from uncontrolled innate immunity to B cell-mediated autoimmunity: MiR-146a in MG thymus","volume":"4","author":"Cavalcante","year":"2023","journal-title":"RRNMF Neuromuscular Journal"},{"issue":"17","key":"10.1016\/j.lfs.2024.122950_bb0660","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.3390\/cells11172746","article-title":"Reduced miR-146a-5p is a biomarker of infant respiratory diseases contributing to immune dysregulation in small airway epithelial cells","volume":"11","author":"Rodrigo-Mu\u00f1oz","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2024.122950_bb0665","doi-asserted-by":"crossref","unstructured":"M. Arroyo, K. Salka, E. Chorvinsky, X. Xuchen, K. Abutaleb, G.F. Perez, J. Weinstock, S. Gaviria, M.J. Gutierrez, G. Nino, Airway mir-155 responses are associated with TH1 cytokine polarization in young children with viral respiratory infections, PloS One 15(5) (2020) e0233352.","DOI":"10.1371\/journal.pone.0233352"},{"key":"10.1016\/j.lfs.2024.122950_bb0670","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s13577-019-00240-w","article-title":"Down-regulation of miR-377 suppresses high glucose and hypoxia-induced angiogenesis and inflammation in human retinal endothelial cells by direct up-regulation of target gene SIRT1","volume":"32","author":"Cui","year":"2019","journal-title":"Hum. Cell"},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-023-02253-y","article-title":"Magnetofection of miR-21 promoted by electromagnetic field and iron oxide nanoparticles via the p38 MAPK pathway contributes to osteogenesis and angiogenesis for intervertebral fusion","volume":"21","author":"Wang","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"9","key":"10.1016\/j.lfs.2024.122950_bb0680","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.3390\/antiox11091675","article-title":"Role of c-miR-21, c-miR-126, redox status, and inflammatory conditions as potential predictors of vascular damage in T2DM patients","volume":"11","author":"L\u00f3pez-Armas","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.lfs.2024.122950_bb0685","first-page":"1","article-title":"Circular RNA circVAPA knockdown suppresses colorectal cancer cell growth process by regulating miR-125a\/CREB5 axis","volume":"20","author":"Zhang","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"1_Supplement","key":"10.1016\/j.lfs.2024.122950_bb0690","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.210.Supp.172.13","article-title":"T cell expressed microRNA-155 promotes antitumor immunity and immune checkpoint blockade responses in colon cancer through repression of Ship1","volume":"210","author":"Tang","year":"2023","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0695","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1038\/s41598-017-07172-1","article-title":"Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression","volume":"7","author":"Sebastiani","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.lfs.2024.122950_bb0700","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.4049\/jimmunol.1900386","article-title":"Monocyte\/macrophage abnormalities specific to rheumatoid arthritis are linked to miR-155 and are differentially modulated by different TNF inhibitors","volume":"203","author":"Paoletti","year":"2019","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0705","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13075-021-02517-8","article-title":"Decreased microRNA-155 in Behcet\u2019s disease leads to defective control of autophagy thereby stimulating excessive proinflammatory cytokine production","volume":"23","author":"Liang","year":"2021","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.lfs.2024.122950_bb0710","first-page":"1973","article-title":"MicroRNA-181b regulates NF-\u03baB-mediated vascular inflammation","volume":"122","author":"Sun","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2024.122950_bb0715","doi-asserted-by":"crossref","first-page":"12972","DOI":"10.1038\/srep12972","article-title":"Significant association between functional microRNA polymorphisms and head and neck cancer susceptibility: a comprehensive meta-analysis","volume":"5","author":"Niu","year":"2015","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.lfs.2024.122950_bb0720","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/jir.2018.0116","article-title":"Role of serum miR-181b, Proinflammatory Cytokine, and Adhesion Molecules in Beh\u00e7et\u2019s Disease","volume":"39","author":"El Boghdady","year":"2019","journal-title":"Journal of interferon & cytokine research\u202f: the official journal of the International Society for Interferon and Cytokine Research"},{"issue":"5","key":"10.1016\/j.lfs.2024.122950_bb0725","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/rheumatology\/ket438","article-title":"Increased notch pathway activation in Beh\u00e7et\u2019s disease","volume":"53","author":"Qi","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.lfs.2024.122950_bb0730","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.3390\/ijms16047413","article-title":"The relevance of miRNA-21 in HSV-induced inflammation in a mouse model","volume":"16","author":"Choi","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.lfs.2024.122950_bb0735","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00439-013-1346-8","article-title":"A functional variant of pre-miRNA-196a2 confers risk for Behcet\u2019s disease but not for Vogt-Koyanagi-Harada syndrome or AAU in ankylosing spondylitis","volume":"132","author":"Qi","year":"2013","journal-title":"Hum. Genet."},{"issue":"6","key":"10.1016\/j.lfs.2024.122950_bb0740","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1084\/jem.20101823","article-title":"miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice","volume":"208","author":"Boldin","year":"2011","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.lfs.2024.122950_bb0745","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejr.2019.07.003","article-title":"Micro RNA 499 gene expression and interleukin 17 in Egyptian patients with Beh\u00e7et\u2019s disease","volume":"42","author":"Elessawi","year":"2020","journal-title":"The Egyptian Rheumatologist"},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0750","first-page":"195","article-title":"Regulatory role of circRNA-0067835 in Behcet disease through targeting Micro RNA-155: implication of ATG1, AKT and MTOR","volume":"12","author":"Saad El-Din","year":"2023","journal-title":"Reports of biochemistry & molecular biology"},{"key":"10.1016\/j.lfs.2024.122950_bb0755","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00018-016-2167-4","article-title":"Contribution of MicroRNAs to autoimmune diseases","volume":"73","author":"Garo","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"12","key":"10.1016\/j.lfs.2024.122950_bb0760","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1002\/jcp.26949","article-title":"The MicroRNA-326: autoimmune diseases, diagnostic biomarker, and therapeutic target","volume":"233","author":"Jadideslam","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"16","key":"10.1016\/j.lfs.2024.122950_bb0765","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2217\/bmm-2019-0098","article-title":"Expression levels of miR-21, miR-146b and miR-326 as potential biomarkers in Behcet\u2019s disease","volume":"13","author":"Jadideslam","year":"2019","journal-title":"Biomark. Med."},{"issue":"3","key":"10.1016\/j.lfs.2024.122950_bb0770","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/annrheumdis-2021-220859","article-title":"A unique circulating miRNA profile highlights thrombo-inflammation in Beh\u00e7et\u2019s syndrome","volume":"81","author":"Emmi","year":"2022","journal-title":"Ann. Rheum. Dis."},{"issue":"6 Suppl 94","key":"10.1016\/j.lfs.2024.122950_bb0775","first-page":"72","article-title":"Global microRNA profiling of peripheral blood mononuclear cells in patients with Behcet\u2019s disease","volume":"33","author":"Erre","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.lfs.2024.122950_bb0780","doi-asserted-by":"crossref","unstructured":"X. Liu, S. Ni, C. Li, N. Xu, W. Chen, M. Wu, A.J. van Wijnen, Y. Wang, Circulating microRNA-23b as a new biomarker for rheumatoid arthritis, Gene 712 (2019) 143911.","DOI":"10.1016\/j.gene.2019.06.001"},{"issue":"7","key":"10.1016\/j.lfs.2024.122950_bb0785","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/nm.2815","article-title":"The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-\u03b1","volume":"18","author":"Zhu","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2024.122950_bb0790","doi-asserted-by":"crossref","unstructured":"S. Pashangzadeh, M. Motallebnezhad, F. Vafashoar, A. Khalvandi, N. Mojtabavi, Implications the role of miR-155 in the pathogenesis of autoimmune diseases, Front. Immunol. 12 (2021) 669382.","DOI":"10.3389\/fimmu.2021.669382"},{"issue":"10","key":"10.1016\/j.lfs.2024.122950_bb0795","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/annrheumdis-2012-202815","article-title":"Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis","volume":"73","author":"Filkov\u00e1","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.lfs.2024.122950_bb0800","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.omtn.2018.02.010","article-title":"MicroRNA-326 upregulates B cell activity and autoantibody production in lupus disease of MRL\/lpr mice, Molecular therapy","volume":"11","author":"Xia","year":"2018","journal-title":"Nucleic acids"},{"issue":"4","key":"10.1016\/j.lfs.2024.122950_bb0805","first-page":"3766","article-title":"Expression of miR-495 and miR-326 in peripheral blood of rheumatoid arthritis patients and its significance","volume":"20","author":"Sui","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.lfs.2024.122950_bb0810","first-page":"188","article-title":"Different phenotypes identified for Beh\u00e7et syndrome","volume":"17","author":"McHugh","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"9","key":"10.1016\/j.lfs.2024.122950_bb0815","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1167\/iovs.12-9832","article-title":"Decreased microRNA-155 expression in ocular Behcet\u2019s disease but not in Vogt Koyanagi Harada syndrome","volume":"53","author":"Zhou","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"16","key":"10.1016\/j.lfs.2024.122950_bb0820","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2217\/bmm-2019-0098","article-title":"Expression levels of miR-21, miR-146b and miR-326 as potential biomarkers in Behcet\u2019s disease","volume":"13","author":"Jadideslam","year":"2019","journal-title":"Biomark. Med."},{"issue":"6","key":"10.1016\/j.lfs.2024.122950_bb0825","first-page":"675","article-title":"Association of reduced heme oxygenase-1 with decreased MicroRNA-196a2 expression in peripheral blood mononuclear cells of patients with intestinal Behcet\u2019s disease","volume":"46","author":"Zou","year":"2016","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0830","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-4362.1991.tb05883.x","article-title":"Treatment of Beh\u00e7et disease with indomethacin","volume":"30","author":"Simsek","year":"1991","journal-title":"Int. J. Dermatol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122950_bb0835","first-page":"493","article-title":"Inefficacy of azapropazone in the acute arthritis of Behcet\u2019s syndrome: a randomized, double blind, placebo controlled study","volume":"13","author":"Moral","year":"1995","journal-title":"Clin. Exp. Rheumatol."},{"issue":"5","key":"10.1016\/j.lfs.2024.122950_bb0840","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjmed.2014.12.010","article-title":"Colchicine: old and new","volume":"128","author":"Slobodnick","year":"2015","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.lfs.2024.122950_bb0845","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.clinthera.2023.01.004","article-title":"The role of colchicine in different clinical phenotypes of Behcet disease","volume":"45","author":"Wang","year":"2023","journal-title":"Clin. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2024.122950_bb0850","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/rheumatology\/kei165","article-title":"A double-blind trial of depot corticosteroids in Beh\u00e7et\u2019s syndrome","volume":"45","author":"Mat","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.lfs.2024.122950_bb0855","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM198202113060615","article-title":"Azathioprine decreases suppressor T cells in patients with multiple sclerosis","volume":"306","author":"Trotter","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2024.122950_bb0860","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.1993.tb17137.x","article-title":"The mechanism of action of FK-506 and cyclosporin A","volume":"696","author":"Wiederrecht","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.lfs.2024.122950_bb0865","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.semarthrit.2003.09.010","article-title":"The use of interferon \u03b1 in beh\u00e7et disease: review of the literature","volume":"33","author":"K\u00f6tter","year":"2004","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.lfs.2024.122950_bb0870","doi-asserted-by":"crossref","unstructured":"T.B. van der Houwen, P.M. van Hagen, J.A.M. van Laar, Immunopathogenesis of Beh\u00e7et's disease and treatment modalities, Semin. Arthritis Rheum. 52 (2022) 151956.","DOI":"10.1016\/j.semarthrit.2022.151956"},{"issue":"3","key":"10.1016\/j.lfs.2024.122950_bb0875","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/bjo.2009.158840","article-title":"Comparison of infliximab versus cyclosporine during the initial 6-month treatment period in Behcet\u2019s disease","volume":"94","author":"Yamada","year":"2009","journal-title":"Br. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122950_bb0880","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/ard.2006.064279","article-title":"Adalimumab: a new modality for Beh\u00e7et\u2019s disease?","volume":"66","author":"Van Laar","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0885","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semarthrit.2010.09.002","article-title":"Anti-TNF agents for Behcet\u2019s disease: analysis of published data on 369 patients","volume":"41","author":"Arida","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.lfs.2024.122950_bb0890","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3109\/s10165-008-0057-9","article-title":"Treatment of retinal vasculitis in Beh\u00e7et\u2019s disease with rituximab","volume":"18","author":"Sadreddini","year":"2008","journal-title":"Mod. Rheumatol."},{"issue":"11","key":"10.1016\/j.lfs.2024.122950_bb0895","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13111586","article-title":"miRNA-based Technologies in Cancer Therapy","volume":"13","author":"Pagoni","year":"2023","journal-title":"Journal of personalized medicine"},{"issue":"3","key":"10.1016\/j.lfs.2024.122950_bb0900","doi-asserted-by":"crossref","DOI":"10.3390\/ncrna3030022","article-title":"miR-146 and miR-155: two key modulators of immune response and tumor development","volume":"3","author":"Testa","year":"2017","journal-title":"Non-coding RNA"},{"issue":"9","key":"10.1016\/j.lfs.2024.122950_bb0905","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1167\/iovs.12-9832","article-title":"Decreased microRNA-155 expression in ocular Behcet\u2019s disease but not in Vogt Koyanagi Harada syndrome","volume":"53","author":"Zhou","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-015-0513-x","article-title":"Reduced miR-29a-3p expression is linked to the cell proliferation and cell migration in gastric cancer","volume":"13","author":"Zhao","year":"2015","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.lfs.2024.122950_bb0915","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2019.10.007","article-title":"MicroRNA delivery through nanoparticles","volume":"313","author":"Lee","year":"2019","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0920","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41544-019-0024-y","article-title":"Recent progress in microRNA-based delivery systems for the treatment of human disease","volume":"1","author":"Fu","year":"2019","journal-title":"ExRNA"},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0925","article-title":"Non-coding RNA and innate immune signal regulation","volume":"53","author":"Xue-mei","year":"2022","journal-title":"Journal of Sichuan University (Medical Science Edition)"},{"issue":"4","key":"10.1016\/j.lfs.2024.122950_bb0930","doi-asserted-by":"crossref","first-page":"e00015","DOI":"10.1128\/cmr.00015-23","article-title":"MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets","volume":"36","author":"Kimura","year":"2023","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.lfs.2024.122950_bb0935","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3389\/fcell.2020.00818","article-title":"MicroRNAs and autoimmune-mediated eye diseases","volume":"8","author":"Wei","year":"2020","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"7","key":"10.1016\/j.lfs.2024.122950_bb0940","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrrheum.2009.106","article-title":"The socioeconomic burden of SLE","volume":"5","author":"Lau","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0945","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3349\/ymj.2012.53.1.35","article-title":"New insights in the clinical understanding of Beh\u00e7et\u2019s disease","volume":"53","author":"Cho","year":"2012","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.lfs.2024.122950_bb0950","first-page":"1","article-title":"Relationship of diffusion tensor imaging parameters with neurocognitive dysfunction in patients with Behcet\u2019s disease","author":"Atasoy","year":"2022","journal-title":"Acta Neurol. Belg."},{"issue":"4","key":"10.1016\/j.lfs.2024.122950_bb0955","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1586\/1744666X.2015.1020301","article-title":"miRNAs in inflammatory skin diseases and their clinical implications","volume":"11","author":"L\u00f8vendorf","year":"2015","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.lfs.2024.122950_bb0960","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1244578","article-title":"Proposing new early detection indicators for pancreatic cancer: combining machine learning and neural networks for serum miRNA-based diagnostic model","volume":"13","author":"Chi","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122950_bb0965","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s42003-020-0863-y","article-title":"A miRNA-based diagnostic model predicts resectable lung cancer in humans with high accuracy","volume":"3","author":"Asakura","year":"2020","journal-title":"Communications biology"},{"issue":"9","key":"10.1016\/j.lfs.2024.122950_bb0970","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3390\/vaccines11091488","article-title":"Combinatorial effects of miRNAs in HSV-2 infection of macrophages: an in silico and in vitro integration approach","volume":"11","author":"Banerjee","year":"2023","journal-title":"Vaccines"},{"issue":"18","key":"10.1016\/j.lfs.2024.122950_bb0975","doi-asserted-by":"crossref","first-page":"10489","DOI":"10.3390\/ijms231810489","article-title":"MicroRNAs, stem cells in bipolar disorder, and lithium therapeutic approach","volume":"23","author":"Coradduzza","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122950_bb0980","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.807895","article-title":"The role of miRNA in tumor immune escape and miRNA-based therapeutic strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2024.122950_bb0985","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/biomedicines11020624","article-title":"Ocular Beh\u00e7et disease\u2014clinical manifestations, treatments and outcomes according to age at disease onset","volume":"11","author":"Ostrovsky","year":"2023","journal-title":"Biomedicines"},{"issue":"22","key":"10.1016\/j.lfs.2024.122950_bb0990","doi-asserted-by":"crossref","first-page":"7008","DOI":"10.3390\/jcm12227008","article-title":"The influence of time on the epidemiology and clinical manifestations of Beh\u00e7et\u2019s disease in Brazil","volume":"12","author":"Hirata","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.lfs.2024.122950_bb0995","series-title":"AB0814 Association Between Uveitis and Other Clinical Manifestations of Ankylosing Spondylitis","author":"Godzenko","year":"2022"},{"issue":"8","key":"10.1016\/j.lfs.2024.122950_bb1000","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3390\/biomedicines10082039","article-title":"Hidradenitis suppurativa: a perspective on genetic factors involved in the disease","volume":"10","author":"Moltrasio","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.lfs.2024.122950_bb1005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tox.2012.12.016","article-title":"The interplay between environmental and genetic factors in Parkinson's disease susceptibility: the evidence for pesticides","volume":"307","author":"Dardiotis","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.lfs.2024.122950_bb1010","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3389\/fgene.2018.00695","article-title":"Crosstalk of genetic variants, allele-specific DNA methylation, and environmental factors for complex disease risk","volume":"9","author":"Wang","year":"2019","journal-title":"Front. Genet."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052400540X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052400540X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T10:26:30Z","timestamp":1725272790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052400540X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":202,"alternative-id":["S002432052400540X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122950","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Approaches based on miRNAs in Beh\u00e7et's Disease: Unveiling pathogenic mechanisms, diagnostic strategies, and therapeutic applications","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"122950"}}